Treatment of primary glioblastoma multiforme with cetuximab [Erbitux; Merck KGaA], radiotherapy and temozolomide (GERT) - phase I/II trial.
Phase of Trial: Phase I/II
Latest Information Update: 07 Dec 2018
At a glance
- Drugs Cetuximab (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions
- Acronyms GERT
- 12 Jul 2011 Planned end date (Feb 2010) added as reported by European Clinical Trials Database.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-003911-63).
- 08 Sep 2006 New trial record.